Profound Medical (PROF) Competitors $6.80 -0.14 (-2.02%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends PROF vs. CBLL, AXGN, BVS, BFLY, AVNS, IRMD, SIBN, BBNX, KIDS, and TMCIShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include CeriBell (CBLL), AxoGen (AXGN), Bioventus (BVS), Butterfly Network (BFLY), Avanos Medical (AVNS), Iradimed (IRMD), SI-BONE (SIBN), Beta Bionics (BBNX), OrthoPediatrics (KIDS), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry. Profound Medical vs. CeriBell AxoGen Bioventus Butterfly Network Avanos Medical Iradimed SI-BONE Beta Bionics OrthoPediatrics Treace Medical Concepts Profound Medical (NASDAQ:PROF) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, community ranking, dividends and earnings. Is PROF or CBLL more profitable? CeriBell has a net margin of 0.00% compared to Profound Medical's net margin of -349.41%. CeriBell's return on equity of 0.00% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-349.41% -85.22% -64.87% CeriBell N/A N/A N/A Do insiders & institutionals believe in PROF or CBLL? 47.9% of Profound Medical shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has stronger valuation & earnings, PROF or CBLL? CeriBell has higher revenue and earnings than Profound Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$10.68M19.15-$28.57M-$1.12-6.08CeriBell$65.44M11.19N/AN/AN/A Does the media refer more to PROF or CBLL? In the previous week, Profound Medical had 3 more articles in the media than CeriBell. MarketBeat recorded 6 mentions for Profound Medical and 3 mentions for CeriBell. Profound Medical's average media sentiment score of 0.77 beat CeriBell's score of 0.32 indicating that Profound Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CeriBell 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer PROF or CBLL? Profound Medical received 31 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 72.73% of users gave Profound Medical an outperform vote. CompanyUnderperformOutperformProfound MedicalOutperform Votes4072.73% Underperform Votes1527.27% CeriBellOutperform Votes9100.00% Underperform VotesNo Votes Do analysts prefer PROF or CBLL? Profound Medical presently has a consensus target price of $14.25, indicating a potential upside of 109.25%. CeriBell has a consensus target price of $32.60, indicating a potential upside of 59.65%. Given Profound Medical's stronger consensus rating and higher probable upside, analysts clearly believe Profound Medical is more favorable than CeriBell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33CeriBell 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryProfound Medical beats CeriBell on 9 of the 15 factors compared between the two stocks. Remove Ads Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$204.57M$4.44B$5.71B$8.11BDividend YieldN/A29.39%4.41%4.09%P/E Ratio-5.0829.0524.2318.92Price / Sales19.1550.38395.0390.28Price / CashN/A51.0838.1634.64Price / Book5.326.237.094.42Net Income-$28.57M$67.64M$3.19B$247.05M7 Day Performance-2.01%6.58%1.58%1.36%1 Month Performance-8.96%-3.42%2.10%-6.51%1 Year Performance-18.54%22.72%14.44%3.12% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical2.4586 of 5 stars$6.81-1.9%$14.25+109.3%-17.1%$204.57M$10.68M-5.08150Short Interest ↑Gap DownCBLLCeriBellN/A$22.21-2.1%$32.60+46.8%N/A$796.63M$65.44M0.00N/AAXGNAxoGen3.0764 of 5 stars$17.17-3.2%$20.75+20.9%+133.1%$761.39M$187.34M-53.66450Insider TradeBVSBioventus3.3024 of 5 stars$8.76-4.8%$15.00+71.2%+69.4%$746.63M$555.06M-14.361,200Positive NewsGap DownBFLYButterfly Network1.5782 of 5 stars$2.54-11.1%$3.00+18.3%+143.8%$692.33M$82.06M-5.51460Gap DownAVNSAvanos Medical2.4898 of 5 stars$14.93-2.0%N/A-24.6%$686.87M$687.80M43.913,771Analyst UpgradeAnalyst RevisionNegative NewsIRMDIradimed4.8577 of 5 stars$51.98-0.4%$72.00+38.5%+17.4%$658.74M$73.24M34.65110Short Interest ↑SIBNSI-BONE4.2591 of 5 stars$15.43-3.9%$24.50+58.8%-6.7%$655.05M$167.18M-16.77350Short Interest ↑Positive NewsBBNXBeta BionicsN/A$14.99-7.1%$24.83+65.7%N/A$642.46M$53.03M0.00294High Trading VolumeKIDSOrthoPediatrics4.1503 of 5 stars$24.49-3.4%$37.25+52.1%-7.3%$594.79M$204.73M-19.91200Insider TradeTMCITreace Medical Concepts1.4351 of 5 stars$8.23-4.0%$10.21+24.1%-34.2%$515.35M$209.36M-8.31250Insider TradeShort Interest ↑ Remove Ads Related Companies and Tools Related Companies CBLL Competitors AXGN Competitors BVS Competitors BFLY Competitors AVNS Competitors IRMD Competitors SIBN Competitors BBNX Competitors KIDS Competitors TMCI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PROF) was last updated on 3/21/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PROF Stock Alerts